Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allal AS, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[18F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002;20:1398–1404.
Braams JW, Pruim J, Freling NJ, et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995;36:211–216.
Delbeke D. Oncological applications of FDG PET imaging: Brain tumors, colorectal cancer, lymphoma, and melanoma. J Nucl Med 1999;40:591–603.
Dresel S, Schwenzer K, Brinkbaumer K, et al. [F-18] FDG imaging of head and neck tumors: Comparison of hybrid PET, dedicated PET and CT. Nuklearmedizin 2001;40(5):172–178.
Ilknur AK, et al. Positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose in oncology: Part II: The clinical value in detecting and staging primary tumours. J Cancer Res Clin Oncol 2000;126:560–574.
de Boer JR, Pruim J, van der Laan B, et al. L-1-11C-Tyrosine PET in patients with laryngeal carcinomas: Comparison of standardized uptake value and protein synthesis rate. J Nucl Med 2003;44:341–346.
Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI,CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 2003;44(2):198–206.
Kostakoglu L, Agress H Jr, Goldsmith SJ, et al. Clinical role of FDG PET in evaluation of cancer patients. Radiographics 2003;23:315–340.
Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI, and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747–1757.
Lonneux M, Lawson G, Ide C, Bausart R, Remacle M, Pauwels S. Positron emission tomography with fluorodeoxyglucose for suspected head and neck tumor recurrence in the symptomatic patient. Laryngoscope. 2000;110(9):1493–1497.
Lowe VJ, Boyd JH, Dunphy FR, et al. Surveillance for recurrent head and neck cancer using positron emission tomography. J Clin Oncol 2000;18(3):651–658.
Lowe VJ, Stack BC Jr. Esophageal cancer and head and neck cancer. Sem Roentgenol 2002;37(2):140–150.
Ojiri H, Mancuso AA, Mendenhall WM, Stringer SP. Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. Am J Neuroradiol 2002;23(10):1627–1631.
Teknos TN, Rosenthal EL, Lee D, Taylor R, Marn S. Positron emission tomography in the evaluation of stage III and IV head and neck cancer. Head Neck 2001;23:1056–1060.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Go, J.L. (2005). Head and Neck Cancers. In: Conti, P.S., Cham, D.K. (eds) PET-CT. Springer, New York, NY. https://doi.org/10.1007/0-387-27044-2_12
Download citation
DOI: https://doi.org/10.1007/0-387-27044-2_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-20858-9
Online ISBN: 978-0-387-27044-9
eBook Packages: MedicineMedicine (R0)